Metraipolis › archive › dc_3ce56b68034b

Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta-Analysis — Europe PMC PMID:41276951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41276951
DOI
10.1002/edm2.70136
License (as archived)
solo-consultazione
Archived
2026-11-08T20:58:36.224Z
SHA-256 of the archived text
b2f18d363bb5ac61dc9dca86bc7c95f8e5b20671a0343ef25680fbfc9fd28275
Stable URL of this page
https://metraipolis.com/documento/dc_3ce56b68034b

How to cite

Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta-Analysis — Europe PMC PMID:41276951 — Europe PMC (en), https://europepmc.org/article/MED/41276951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ce56b68034b (Metraipolis archive dc_3ce56b68034b, sha256 b2f18d363bb5ac61dc9dca86bc7c95f8e5b20671a0343ef25680fbfc9fd28275)
BibTeX
@misc{dc3ce56b68034b,
  title = {Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta-Analysis — Europe PMC PMID:41276951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41276951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ce56b68034b; sha256 b2f18d363bb5ac61dc9dca86bc7c95f8e5b20671a0343ef25680fbfc9fd28275},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41276951. Agents can read the archived copy with the MCP tool read_document.